Assembly Biosciences (ASMB) Current Assets (2010 - 2026)

Assembly Biosciences' Current Assets history runs 17 years deep, the most recent figure standing at $232.6 million for Q1 2026.

• In Q1 2026, Current Assets rose 143.5% year-over-year to $232.6 million; the TTM figure through Mar 2026 stood at $232.6 million (up 143.5% YoY), while the FY2025 annual figure was $254.5 million, up 120.38% from the prior year.
• Current Assets was $232.6 million for Q1 2026 at Assembly Biosciences, down from $254.5 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $254.5 million in Q4 2025 to a low of $49.7 million in Q3 2023.
• Historically, Current Assets has averaged $125.6 million across 5 years, with a median of $115.1 million in 2022.
• The sharpest annual moves came in 2023 and 2026: Current Assets slumped 56.84% in 2023, then surged 143.5% in 2026.
• A 5-year view of Current Assets shows it stood at $97.0 million in 2022, then jumped by 37.97% to $133.8 million in 2023, then dropped by 13.67% to $115.5 million in 2024, then surged by 120.38% to $254.5 million in 2025, then declined by 8.62% to $232.6 million in 2026.
• The last three Current Assets figures came in at $232.6 million (Q1 2026), $254.5 million (Q4 2025), and $236.8 million (Q3 2025), per Business Quant data.